The objective of this study was to characterize the rhesus macaque (RM) as a model for inhalational brucellosis in support of the U.S. Food and Drug Administration's (FDA) Animal Rule. The pathophysiology of chronic Brucella melitensis aerosol infection was monitored in two phases that each occurred over an 8-week time period; dose escalation (8 RMs; targeted doses of 5.0E؉03, 5.0E؉04, or 5.0E؉05 CFU/animal or the unchallenged control) and natural history (12 RMs; targeted dose of 2.50E؉05 CFU/ animal or the unchallenged control). RMs given an aerosol challenge with B. melitensis developed undulating fevers (6/6 phase I; 8/9 phase II), positive enriched blood cultures (5/10; phase II), and bacterial burdens in tissues starting 14 to 21 days postchallenge (6/6 phase I; 10/10 phase II). In addition, 80% (8/10; phase II) of infected RMs seroconverted 14 to 21 days postchallenge. RMs developed elevations in certain liver enzymes and had an increased inflammatory response by 3 weeks postchallenge as shown by increases in C-reactive protein (6/8) and neopterin (4/8), which correlated with the onset of a fever. As early as 14 days postchallenge, positive liver biopsy specimens were detected (2/8), and ultrasound imaging showed the development of splenomegaly. Finally, histopathologic examination found lesions attributed to Brucella infection in the liver, kidney, lung, and/or spleen of all animals. The disease progression observed with the RMs in this study is analogous to human brucellosis pathophysiology. Thus, the results from this study support the use of the RM as an animal model for inhalational brucellosis to evaluate the efficacy of novel vaccines and therapeutics against B. melitensis. Brucella is a Gram-negative coccobacillus that includes certain species that can cause disease in animals and humans. Brucella melitensis, one of the major species of Brucella, is an etiologic agent for brucellosis. This highly infectious pathogen can infect animals and humans, and it is considered to be one of the most severe human pathogens in the Brucella genus (25). Humans are usually infected following contact with infected animals or ingestion of contaminated milk, milk products, and meat. In addition, brucellosis is one of the most common laboratory-acquired infections, as well as the most common zoonosis (11). While B. melitensis is not typically considered a lethal pathogen in humans (less than 5% fatality rate), it can cause significant disease. Human brucellosis presents as a prolonged febrile illness with flu-like symptoms, such as night sweats, headache, depression, and arthritis. Chronic illness can lead to meningitis and endocarditis. In addition, relapses can occur, even with antibiotic treatment (13). Notably, humans can remain asymptomatic for weeks, months, or even years while infected with this pathogen (3).Brucella species are considered potential biological warfare agents due to their high infectivity, ability to debilitate infected people, and the persistent nature of human disease. In addition, Brucella i...
Tuberculosis has existed in Southeast Asia for thousands of years. Many traditional treatments involve herbal remedies. Over time, these traditional treatments have had the chance to become refined based on efficacy and safety. It was therefore hypothesized that plants that were used in the past and are still used today to treat symptoms associated with tuberculosis are more likely to contain anti-tubercular compounds than plants that have not been used continuously. To try to deduce which plants were used in Laos in the past, a collection of palm leaf manuscripts was studied and a list of plants used to treat symptoms associated with tuberculosis was compiled. Interviews were then conducted with contemporary healers to see if the same plants are still being used today. Plants that were found in the manuscripts and/or are presently used by healers were collected, extracted and were evaluated in an anti-tubercular assay. This paper presents the methods used to identify and collect plants used to treat symptoms indicative of tuberculosis, and the results of anti-TB assays to test for activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.